PATRICK J BUSHARD
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology LAFAYETTE, CO NPI 1306998448
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology CO ABBVIE INC. All categories
General Payments — all program years on this page
$3,730.19
- Category: General Payments
- Program years: PY2018–2024
- Record count: 221
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,789.01 across 99 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,789.01 | 99 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $381.22 | 30 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $142.75 | 6 |
| MDD US Operations, LLC | $140.56 | 8 |
| PFIZER INC. | $133.08 | 15 |
| Lilly USA, LLC | $131.86 | 6 |
| UCB, Inc. | $124.53 | 3 |
| CSL Behring | $116.81 | 4 |
| Celgene Corporation | $65.70 | 2 |
| Neurocrine BioSciences, Inc. | $58.60 | 3 |
| Teva Pharmaceuticals USA, Inc. | $52.47 | 3 |
| SCILEX PHARMACEUTICALS INC. | $51.10 | 3 |
| Otsuka America Pharmaceutical, Inc. | $50.95 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $48.87 | 2 |
| ACADIA Pharmaceuticals Inc | $39.09 | 2 |
| Vanda Pharmaceuticals Inc. | $38.66 | 1 |
| Merz Pharmaceuticals, LLC | $35.22 | 1 |
| Genentech USA, Inc. | $30.32 | 1 |
| Biogen, Inc. | $29.54 | 2 |
| Kyowa Kirin, Inc. | $26.78 | 1 |
| Acerta Pharma LLC | $26.52 | 1 |
| Abbott Laboratories | $23.36 | 1 |
| Amneal Pharmaceuticals LLC | $21.14 | 1 |
| Medtronic, Inc. | $19.88 | 1 |
By program year
Records — PY2024 (99)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.